Given the role of the ubiquitin-conjugating enzyme, possibly a strong association of AD, the existence of the Ube2h gene in various tissue, including blood, is expected to be a new potential biomarker for prediction and diagnosis of AD without brain biopsy or cerebrospinal fluid (CSF) detection. This evidence concerns the gene UBE2H and Alzheimer disease.